LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company (the Company), announced the design of the Phase II trial of alisertib for the treatment of patients ...
HERZOGENAURACH, Germany--(BUSINESS WIRE)--Sports company PUMA is looking for 500 people in Germany to join brand ambassadors such as Cara Delevingne and Raphaël Varane to test the RE:SUEDE sneaker and ...
Puma Biotechnology, Inc. (PBYI), a development stage biopharmaceutical company, announced top line results from the Phase III clinical trial of Puma's investigational drug PB272 (neratinib) for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results